TWO INJECTIVE ETFs ARE NOW PENDING SEC REVIEW.

Canary Capital. 21Shares. Both filed. Both under review.

Injective just joined the ETF conversation alongside BTC, ETH, $SOL , $XRP , LINK, AVAX, and HBAR.

Not a rumor. Not a "planned filing." Submitted and pending.

Native USDC from Circle. AI agent infrastructure live. CME-grade derivatives built into the protocol. Deflationary burns accelerating.

And now two separate asset managers independently decided that $INJ deserves an ETF.

The protocols getting ETF filings aren't random. They're the ones with institutional-grade infrastructure that compliance teams can underwrite.

Injective built that infrastructure from day one. The ETFs are the validation.

- by AltcoinBuzz

XRP

1.3425

+0.29%

SOL

84.07

+1.78%

INJ

--

--